101 related articles for article (PubMed ID: 22703859)
1. Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
Gonzales M; Fratianni C; Mamillapali C; Khardori R
Med Clin North Am; 2012 May; 96(3):635-54, xi. PubMed ID: 22703859
[TBL] [Abstract][Full Text] [Related]
2. [Novel treatment opportunities in Graves' orbitopathy].
Erdei A; Gazdag A; Bodor M; Berta E; Katkó M; Ujhelyi B; Steiber Z; Győry F; Urbancsek H; Barna S; Galuska L; Nagy VE
Orv Hetil; 2014 Aug; 155(33):1295-300. PubMed ID: 25109914
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying.
Bartalena L; Tanda ML
J Endocrinol Invest; 2006 Dec; 29(11):1012-6. PubMed ID: 17259800
[No Abstract] [Full Text] [Related]
4. Omalizumab treatment in a child with severe asthma and multiple steroid-induced morbidities.
Rizk C; Ring A; Santucci S; MacLusky I; Karsh J; Yang WH
Ann Allergy Asthma Immunol; 2012 Sep; 109(3):222-3. PubMed ID: 22920081
[No Abstract] [Full Text] [Related]
5. Omalizumab in the treatment of asthma.
Tan R; Corren J
Expert Rev Respir Med; 2011 Dec; 5(6):747-56. PubMed ID: 22082161
[TBL] [Abstract][Full Text] [Related]
6. Use of omalizumab to improve desensitization safety in allergen immunotherapy.
Larenas-Linnemann D; Wahn U; Kopp M
J Allergy Clin Immunol; 2014 Mar; 133(3):937-937.e2. PubMed ID: 24581432
[No Abstract] [Full Text] [Related]
7. Omalizumab: just what we needed.
Torres-Borrego J
Allergol Immunopathol (Madr); 2014; 42(1):1-2. PubMed ID: 24529608
[No Abstract] [Full Text] [Related]
8. Practical Guidelines Management of Graves Ophthalmopathy.
Subekti I; Soewondo P; Soebardi S; Darmowidjojo B; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Kurniawan F; Sidik M; Nusanti S; Dewiputri S; Suharko H; Suardana GG; Suroyo I; Wulani V; Siswoyo AD; Gondhowiardjo S; Kodrat H
Acta Med Indones; 2019 Oct; 51(4):364-371. PubMed ID: 32041923
[TBL] [Abstract][Full Text] [Related]
9. [Update on endocrine orbitopathy].
Ponto KA; Kahaly GJ; Pitz S
Klin Monbl Augenheilkd; 2009 Feb; 226(2):R13-28; quiz R29-31. PubMed ID: 19206039
[No Abstract] [Full Text] [Related]
10. [Biotherapies for the treatment of asthma: are they the treatment of the future?].
Tonnel AB; Denis G; Lelong J
Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S44-10S48. PubMed ID: 17127963
[No Abstract] [Full Text] [Related]
11. [Current management of endocrine orbitopathy].
Ponto KA; Kahaly GJ
Med Klin (Munich); 2008 Oct; 103(10):717-30; quiz 729-30. PubMed ID: 18936897
[No Abstract] [Full Text] [Related]
12. [Omalizumab treatment in patients with asthma: summary of Meir Medical Center experience with 47 patients].
Shitrit D; Talker O; Metabichek A; Yaakovi I
Harefuah; 2012 Apr; 151(4):216-9, 254, 253. PubMed ID: 22616149
[TBL] [Abstract][Full Text] [Related]
13. [Anti-cytokine and anti-lymphocyte monoclonal antibodies in the treatment of thyroid associated ophthalmopathy].
Komorowski J; Jankiewicz-Wika J; Siejka A; Lawnicka H; Stepień H
Pol Merkur Lekarski; 2007 Jun; 22(132):571-4. PubMed ID: 17874632
[TBL] [Abstract][Full Text] [Related]
14. Role of immunmodulators in allergen-specific immunotherapy.
Kopp MV
Allergy; 2011 Jun; 66(6):792-7. PubMed ID: 21332502
[TBL] [Abstract][Full Text] [Related]
15. Intractable graves ophthalmopathy?
Castillo F; Garrity JA; Kravitz DJ
JAMA Ophthalmol; 2013 Feb; 131(2):269-70. PubMed ID: 23411907
[No Abstract] [Full Text] [Related]
16. [Treatment of thyroid ophthalmopathy--a clinical case].
Andrei S; Zemba M; Zugravu V; Enache V; Renetti A; Spiroiu C
Oftalmologia; 2007; 51(1):49-55. PubMed ID: 17605272
[TBL] [Abstract][Full Text] [Related]
17. The evaluation and treatment of graves ophthalmopathy.
Stan MN; Garrity JA; Bahn RS
Med Clin North Am; 2012 Mar; 96(2):311-28. PubMed ID: 22443978
[TBL] [Abstract][Full Text] [Related]
18. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
Rubin AS; Souza-Machado A; Andradre-Lima M; Ferreira F; Honda A; Matozo TM;
J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
[TBL] [Abstract][Full Text] [Related]
19. A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma.
Bardelas J; Figliomeni M; Kianifard F; Meng X
J Asthma; 2012 Mar; 49(2):144-52. PubMed ID: 22277052
[TBL] [Abstract][Full Text] [Related]
20. Concomitant asthma medication use in patients receiving omalizumab: results from three large insurance claims databases.
Lafeuille MH; Duh MS; Zhang J; Wertz D; Gu T; Swensen A; Lefebvre P
J Asthma; 2011 Nov; 48(9):923-30. PubMed ID: 21978232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
